Diego Bagnasco | Medical | Best Researcher Award

Posted on by ScienceFather

Prof. Diego Bagnasco | Medical | Best Researcher Award

Department of Internal Medicine at University of Genoa, Italy.

Dr. Diego Bagnasco is an Assistant Professor at the Department of Internal Medicine and Medical Specialties, School of Medical and Pharmaceutical Sciences, University of Genoa, Italy. He specializes in allergy and respiratory diseases, focusing on asthma and biologic treatments. Dr. Bagnasco has contributed significantly to research on severe asthma, allergen immunotherapy, and personalized medicine. He has worked at the Azienda Ospedaliera Universitaria San Martino (IRCCS) in Genoa and has published extensively in peer-reviewed journals. His work aims to improve treatment strategies for respiratory conditions through innovative and targeted therapies​.

Professional profile:

Google Scholar

Education & Experience 🎓💼

✅ Doctorate: Ph.D. in Medical Sciences, University of Genoa
✅ Assistant Professor: University of Genoa, Department of Internal Medicine and Medical Specialties
✅ Research Assistant: Azienda Ospedaliera Universitaria San Martino (IRCCS), Genoa
✅ Expertise: Severe asthma, biologic therapies, allergen immunotherapy, personalized medicine​

Professional Development 🚀📚

Dr. Bagnasco actively contributes to advancements in allergy and respiratory diseases through research, teaching, and clinical practice. He collaborates with leading institutions and researchers in the field to explore innovative approaches to asthma treatment. His studies focus on the long-term effects of biologics and immunotherapy, aiming to enhance personalized treatment options for patients. As a key figure in respiratory medicine, he participates in international conferences, peer reviews articles for top-tier journals, and mentors students in medical sciences. His dedication to translational research bridges the gap between clinical practice and scientific discovery.

Research Focus 🔬🩺

Dr. Bagnasco’s research revolves around severe asthma, allergen immunotherapy, and biologic treatments. He investigates how biologics, such as mepolizumab, affect asthma patients and the risks associated with discontinuation. His work also explores personalized treatment strategies for respiratory diseases, with a particular emphasis on precision medicine. His contributions aim to improve patient outcomes by identifying biomarkers for targeted therapies, reducing asthma exacerbations, and optimizing long-term management plans for individuals with severe respiratory conditions​.

Awards & Honors 🏆🎖

✔️ Recognized expert in allergy and respiratory diseases
✔️ Published in high-impact medical journals
✔️ Contributor to international conferences on asthma and immunotherapy
✔️ Reviewer and editorial board member for allergy and respiratory journals
✔️ Collaborator in major research projects on biologic treatments​

Publication Top Notes

  • A critical evaluation of anti-IL-13 and anti-IL-4 strategies in severe asthma – D Bagnasco, M Ferrando, G Varricchi, G Passalacqua, GW Canonica, 277 citations, 2016.
  • Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs – G Varricchi, D Bagnasco, F Borriello, E Heffler, GW Canonica, 245 citations, 2016.
  • Type 2 immunity in asthma – M Caminati, DL Pham, D Bagnasco, GW Canonica, 193 citations, 2018.
  • Minimal clinically important difference for asthma endpoints: an expert consensus report – M Bonini, M Di Paolo, D Bagnasco, I Baiardini, F Braido, M Caminati, …, 154 citations, 2020.
  • Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19 – J Bousquet, JM Anto, W Czarlewski, T Haahtela, SC Fonseca, G Iaccarino, …, 147 citations, 2021.

Dr. Stavros Melemenidis | Nanotheranostics Awards | Best Researcher Award

Posted on by ScienceFather

Dr. Stavros Melemenidis | Nanotheranostics Awards | Best Researcher Award

Dr. Stavros Melemenidis , Stanford University School of Medicine , United States

Stavros Melemenidis, DPhil, is a distinguished figure in the field of Radiation Oncology, currently serving as Director of Pre-clinical Radiotherapy and Research Scientist at Stanford University’s Department of Radiation Oncology in Stanford, CA, USA. He completed his DPhil in Radiation Biology at the University of Oxford, where his research focused on molecular targeted imaging methods for lung metastasis and angiogenesis detection. Dr. Melemenidis holds a diverse educational background including degrees from UCLA and the University of Liverpool. His expertise spans preclinical radiotherapy, ultra-high dose-rate irradiation experiments, and the development of advanced imaging probes and animal models for cancer research. Dr. Melemenidis is recognized for his contributions to radiation therapy and imaging sciences, employing innovative techniques to advance cancer treatment and research.

Professional Profile:

Scopus

🎓Education:

Stavros Melemenidis, DPhil, has pursued an extensive educational journey encompassing a diverse array of disciplines. He earned his DPhil in Radiation Biology from the University of Oxford, UK, focusing on the development of molecular targeted imaging methods for the detection of lung metastasis and angiogenesis. His academic credentials also include a Cert. in Medical Physics from UCLA, USA, an M.Sc. in Radiation Biology from the University of Oxford, UK, and an M.Sc. in Radiometrics; Instrumentation and Modelling from the University of Liverpool, UK. Dr. Melemenidis began his academic path with a B.Sc. in Physics: Medical Applications from the University of Liverpool and an A.Eng. in PC Systems and Peripheral Equipment from IIEK Neapoleos, Technical College, Greece. This diverse educational background has equipped him with expertise spanning radiation biology, medical physics, instrumentation, and modelling, contributing significantly to his research and leadership roles in the field of Radiation Oncology at Stanford University.

🏢Work Experience:

Stavros Melemenidis, DPhil, holds key positions in the field of Radiation Oncology at Stanford University in Stanford, CA, USA. Since January 2023, he has served as the Director of Pre-clinical Radiotherapy within the Department of Radiation Oncology, overseeing advanced research initiatives. Prior to this role, Dr. Melemenidis has been integral to the Division of Radiation Therapy as a Research Scientist since February 2020, contributing to innovative studies in radiation oncology. His earlier career includes impactful roles as a Postdoctoral Fellow at Stanford University from February 2016 to June 2020, where he focused on developing in vivo mouse tumor models and integrating imaging techniques with radiotherapy and immunotherapy. Previously, he was a Postdoctoral Fellow at the University of Oxford’s Department of Radiation Oncology from January 2015 to September 2015, conducting research on novel imaging probes for metastasis and angiogenesis detection. These experiences underscore Dr. Melemenidis’s dedication to advancing preclinical and clinical applications in radiation oncology through pioneering research and leadership.

Publication Top Notes:

  • Human enteroids as a tool to study conventional and ultra-high dose rate radiation
    • Authors: Klett, K.C., Martin-Villa, B.C., Villarreal, V.S., Loo Jr, B.W., Heilshorn, S.C.
    • Citations: 1
  • Real-time optical oximetry during FLASH radiotherapy using a phosphorescent nanoprobe
    • Authors: Ha, B., Liang, K., Liu, C., Loo, B.W., Pratx, G.
    • Citations: 4
  • Endogenous Retroviral Elements Generate Pathologic Neutrophils in Pulmonary Arterial Hypertension
    • Authors: Taylor, S., Isobe, S., Cao, A., Snyder, M.P., Rabinovitch, M.
    • Citations: 10
  • Design and validation of a dosimetric comparison scheme tailored for ultra-high dose-rate electron beams to support multicenter FLASH preclinical studies
    • Authors: Jorge, P.G., Melemenidis, S., Grilj, V., Loo, B.W., Bailat, C.
    • Citations: 9